---
title: "Adaptive Biotech CSO Harlan S. Robins disposes of USD 8.49 million in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291984579.md"
description: "Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 386,240 common shares on July 2, 2026, valued at approximately USD 8.49 million. The transaction price ranged from USD 21.74 to USD 22.45 per share. Following this sale, Robins' directly owned stake decreased to 1,019,658 shares. The information was published via EDGAR on July 7, 2026."
datetime: "2026-07-07T22:53:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291984579.md)
  - [en](https://longbridge.com/en/news/291984579.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291984579.md)
---

# Adaptive Biotech CSO Harlan S. Robins disposes of USD 8.49 million in common shares

-   Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 386,240 common shares on July 2, 2026. \* Sales priced at USD 21.74 to USD 22.45 per share. \* Directly owned stake fell to 1,019,658 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780851-26-000015), on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ADPT.US](https://longbridge.com/en/quote/ADPT.US.md)

## Related News & Research

- [Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 1,299 common shares for $31,176](https://longbridge.com/en/news/294743960.md)
- [Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million](https://longbridge.com/en/news/293677690.md)
- [Covivio announces availability of 2026 half-year report](https://longbridge.com/en/news/294781698.md)
- [Runway Growth Finance declares Q3 2026 dividend of $0.33 a share](https://longbridge.com/en/news/295012082.md)
- [Mobilezone schedules investor video conference on H1 2026 results](https://longbridge.com/en/news/294935560.md)